Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31787
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Koshy, Anoop N | - |
dc.contributor.author | Giustino, Gennaro | - |
dc.contributor.author | Sartori, Samantha | - |
dc.contributor.author | Kyaw, Htoo | - |
dc.contributor.author | Yadav, Mayank | - |
dc.contributor.author | Zhang, Zhongjie | - |
dc.contributor.author | Hooda, Amit | - |
dc.contributor.author | Farooq, Ali | - |
dc.contributor.author | Krishnamoorthy, Parasuram | - |
dc.contributor.author | Sweeny, Joseph M | - |
dc.contributor.author | Khera, Sahil | - |
dc.contributor.author | Serrao, Gregory W | - |
dc.contributor.author | Sharma, Raman | - |
dc.contributor.author | Suleman, Javed | - |
dc.contributor.author | Dangas, George | - |
dc.contributor.author | Kini, Annapoorna S | - |
dc.contributor.author | Mehran, Roxana | - |
dc.contributor.author | Sharma, Samin K | - |
dc.date.accessioned | 2023-01-12T03:02:38Z | - |
dc.date.available | 2023-01-12T03:02:38Z | - |
dc.date.issued | 2022-11-28 | - |
dc.identifier.citation | JACC. Cardiovascular Interventions 2022; 15(22) | en_US |
dc.identifier.issn | 1876-7605 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/31787 | - |
dc.description.abstract | Potent P2Y12 agents such as ticagrelor and prasugrel are increasingly utilized across the clinical spectrum of patients undergoing percutaneous coronary intervention (PCI). There is a paucity of data supporting their use in a patient population inclusive of both acute coronary syndrome (ACS) and chronic coronary syndrome (CCS) patients. | en_US |
dc.language.iso | eng | - |
dc.subject | acute coronary syndrome | en_US |
dc.subject | antiplatelet therapy | en_US |
dc.subject | chronic coronary syndrome | en_US |
dc.subject | major adverse cardiovascular event(s) | en_US |
dc.subject | percutaneous coronary intervention | en_US |
dc.subject | stable ischemic heart disease | en_US |
dc.title | Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary Intervention. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | JACC. Cardiovascular Interventions | en_US |
dc.identifier.affiliation | The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Cardiology, Austin Health, University of Melbourne, Melbourne, Victoria, Australia. | en_US |
dc.identifier.affiliation | Cardiology | en_US |
dc.identifier.affiliation | the Center for Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA | en_US |
dc.identifier.affiliation | The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. | en_US |
dc.identifier.doi | 10.1016/j.jcin.2022.09.021 | en_US |
dc.type.content | Text | en_US |
dc.identifier.pubmedid | 36423970 | - |
dc.description.volume | 15 | - |
dc.description.issue | 22 | - |
dc.description.startpage | 2270 | - |
dc.description.endpage | 2280 | - |
dc.subject.meshtermssecondary | Prasugrel Hydrochloride/adverse effects | - |
dc.subject.meshtermssecondary | Ticagrelor/adverse effects | - |
dc.subject.meshtermssecondary | Percutaneous Coronary Intervention/adverse effects | - |
dc.subject.meshtermssecondary | Acute Coronary Syndrome/diagnostic imaging | - |
dc.subject.meshtermssecondary | Acute Coronary Syndrome/therapy | - |
dc.subject.meshtermssecondary | Stroke/etiology | - |
local.name.researcher | Koshy, Anoop N | |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Cardiology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.